5-azetidin-3-yl-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole hydrochloride, 95.0%, 250mg

2-etilhexilal, SOLVAGREEN® mínimo 99 %, para síntesis, 500 ml, envase de vidrio

4-Methyl-6-thiophen-2-yl-pyrimidin-2-ylamine, 99.0%, 250mg

6-Bromo-3-chloro-2,4-difluorobenzoic acid, 97%, 1g

N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-bis((tert-butyldimethylsilyl)oxy)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95%, 1g

2-Amino-6-methyl-4,5,6,7-tetrahydro-thieno[2,3- c]pyridine-3-carboxylic acid amide, 95.0%, 100g

7-CHLORO-4-FLUORO-1-INDANONE, 95.0%, 10g

2-(3-Bromo-phenoxy)-ethylamine, 95.0%, 100mg

(2e)-3-(2-Bromopyridin-4-yl)prop-2-enoic acid, 95+%, 250mg

3,4,5-TRIS(DODECYLOXY)BENZALDEHYDE, 98%, 25g

3-Chloro-2-iodobenzotrifluoride, 97.0%, 250mg

4-CHLORO-3-METHYLBENZO[B]THIOPHENE-2-CARBOXYLIC ACID, 95.0%, 1g

Ethyl 3-(4-Chlorophenyl)-1H-pyrazole-5-carboxylate, 95.0%, 1g